Paul Tudor Jones’s Medifast MED Stock Holding History

Paul Tudor Jones’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,500	Closed	-$155K	–	3561
2025 Q1	$155K	Sell	11,500 -33,000	-74%	-$496K	﹤0.01%	2903
2024 Q4	$784K	Buy	44,500 +16,200	+57%	+$301K	﹤0.01%	1901
2024 Q3	$542K	Buy	+28,300	New	+$545K	﹤0.01%	1989
2023 Q3	–	Sell	-4,000	Closed	-$369K	–	2632
2023 Q2	$369K	Buy	+4,000	New	+$356K	﹤0.01%	1883
2023 Q1	–	Sell	-6,200	Closed	-$716K	–	2746
2022 Q4	$716K	Buy	+6,200	New	+$722K	0.01%	1347

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Paul Tudor Jones's MED Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Medifast (MED) in Q2 2026: 76,031 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #2563 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in MED as recently as Q2 2024.

Paul Tudor Jones first reported a position in MED in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.81M in Q2 2019. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Paul Tudor Jones held 76,031 shares of Medifast worth $807K as of Q2 2026.
Medifast was a new Paul Tudor Jones position in Q2 2026.
Medifast made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2563 holding.
Paul Tudor Jones first reported a position in Medifast in Q2 2013 and has held it in 17 quarters since.
Paul Tudor Jones's Medifast position peaked at $3.81M in Q2 2019.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.